Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,839 | -17,082 | -10,272 | -11,185 | -3,745 |
| Depreciation Amortization | 1 | 9 | 8 | 7 | 4 |
| Accounts payable and accrued liabilities | -1,308 | -248 | N/A | N/A | N/A |
| Other Working Capital | -1,931 | -56 | -2,713 | -2,294 | -2,977 |
| Other Operating Activity | 1,658 | 426 | 259 | 1,459 | -1,021 |
| Operating Cash Flow | $-7,418 | $-16,950 | $-12,717 | $-12,013 | $-7,740 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 25,074 | 19,082 | 19,082 | 9,878 |
| Financing Cash Flow | $N/A | $25,074 | $19,082 | $19,082 | $9,878 |
| Exchange Rate Effect | 31 | 201 | 222 | -54 | -48 |
| Beginning Cash Position | 14,056 | 5,732 | 5,732 | 5,732 | 5,732 |
| End Cash Position | 6,668 | 14,056 | 12,318 | 12,746 | 7,822 |
| Net Cash Flow | $-7,388 | $8,324 | $6,586 | $7,015 | $2,091 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,418 | -16,950 | -12,717 | -12,013 | -7,740 |
| Free Cash Flow | -7,418 | -16,950 | -12,717 | -12,013 | -7,740 |